Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
445.00
-11.00 (-2.41%)
Aug 27, 2026, 3:30 PM JST

Kringle Pharma Cash Flow Statement

Millions JPY. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-914-754-852-330-299
Other Operating Activities
13015514734184
Change in Accounts Receivable
-7-7699
Change in Inventory
4469-14-34-268
Change in Accounts Payable
-16-13511821-41
Change in Other Net Operating Assets
1-3-8111-135
Operating Cash Flow
-755-661-68915-560
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Investment in Securities
-131-121-120-254-
Other Investing Activities
-23----
Investing Cash Flow
-154-121-120-254-

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Issuance of Common Stock
8483869603612
Other Financing Activities
-----17
Financing Cash Flow
8483869603595

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Miscellaneous Cash Flow Adjustments
--1---1
Net Cash Flow
-82555-74036434

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Levered Free Cash Flow
-581.13-552.63-538.63-185.25-505.75
Unlevered Free Cash Flow
-581.13-552.63-538.63-185.25-505.75

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Income Tax Paid
111-61
Change in Working Capital
29-62164-345